Kiora Pharmaceuticals, Inc.
Clinical trials sponsored by Kiora Pharmaceuticals, Inc., explained in plain language.
-
Experimental eye shot aims to restore sight in Late-Stage blindness
Disease control Recruiting nowThis study tests an experimental drug called KIO-301, given as an eye injection, for people with late-stage retinitis pigmentosa—a disease that causes vision loss. The trial includes 36 adults who have no light perception or very low vision. Participants will receive up to three …
Phase: PHASE2 • Sponsor: Kiora Pharmaceuticals, Inc. • Aim: Disease control
Last updated May 17, 2026 07:39 UTC
-
New shot could drain swollen eyes, early trial begins
Disease control Recruiting nowThis study tests an experimental drug called KIO-104, given as an eye injection, to treat macular edema (swelling in the back of the eye). The main goal is to check safety and tolerability in 28 adults aged 18 to 85. The drug aims to reduce fluid buildup and improve vision, but t…
Phase: PHASE2 • Sponsor: Kiora Pharmaceuticals, Inc. • Aim: Disease control
Last updated May 13, 2026 16:02 UTC